Stock Events

Stock Events

ProstaLund AB 

SEK0.21
2
-SEK0.12-35.15% Friday 11:43

Statistics

Day High
0.27
Day Low
0.2
52W High
11.88
52W Low
0.15
Volume
305,329
Avg. Volume
267,223
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

25FebExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.21
-0.81
-0.4
-0
Expected EPS
N/A
Actual EPS
N/A

Financials

-164.89%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
13.73MRevenue
-22.63MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PLUN.ST. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap9.38B
Baxter International Inc. offers medical devices and therapies that compete in the urology and prostate health market, similar to ProstaLund's core focus.
Medtronic
MDT
Mkt Cap106.97B
Medtronic plc provides medical technologies, services, and solutions, including treatments for urological disorders, directly competing with ProstaLund's products.
Boston Scientific
BSX
Mkt Cap92.25B
Boston Scientific Corporation specializes in medical devices that are used in various therapies including those for urological health, competing with ProstaLund.
EDAP TMS.
EDAP
Mkt Cap120.69M
EDAP TMS SA specializes in therapeutic ultrasound and HIFU technology for treating prostate cancer, directly competing with ProstaLund's technologies.
Intuitive Surgical
ISRG
Mkt Cap170.78B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, some of which are used for prostate surgeries, competing with ProstaLund's treatment options.
Danaher
DHR
Mkt Cap125.45B
Danaher Corporation's medical division offers products and technologies that compete in the broader medical device market, including urology.
Edwards Lifesciences
EW
Mkt Cap48.52B
Edwards Lifesciences Corporation is involved in patient-focused medical innovations for structural heart disease and critical care monitoring, competing in the medical device sector.
Johnson & Johnson
JNJ
Mkt Cap547.64B
Johnson & Johnson engages in the research and development, manufacture and sale of a broad range of products in the healthcare field, indirectly competing with ProstaLund through its medical devices segment.

About

ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow, a temporary prostate stent; Oruflow, a urine flow meter; and Schelin Catheter, a medical device intended for intraprostatic and periprostatic injection of legally market drugs. Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden. ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
Show more...
CEO
Ms. Annette Colin
Employees
6
Country
Sweden
ISIN
SE0002372318

Listings

0 Comments

Share your thoughts

FAQ

What is ProstaLund AB stock price today?▼
The current price of PLUN.ST is SEK0.21 SEK — it has decreased by -35.15% in the past 24 hours. Watch ProstaLund AB stock price performance more closely on the chart.
What is ProstaLund AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ProstaLund AB stocks are traded under the ticker PLUN.ST.
Is ProstaLund AB stock price growing?▼
PLUN.ST stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year ProstaLund AB has showed a -97.11% decrease.
What is ProstaLund AB revenue for the last year?▼
ProstaLund AB revenue for the last year amounts to 13.73M SEK.
What is ProstaLund AB net income for the last year?▼
PLUN.ST net income for the last year is -22.63M SEK.
How many employees does ProstaLund AB have?▼
As of April 29, 2026, the company has 6 employees.
In which sector is ProstaLund AB located?▼
ProstaLund AB operates in the Health & Wellness sector.
When did ProstaLund AB complete a stock split?▼
The last stock split for ProstaLund AB was on December 23, 2024 with a ratio of 1:40.
Where is ProstaLund AB headquartered?▼
ProstaLund AB is headquartered in Lund, Sweden.